• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Antioxidant supplementation did not decrease risk of dementia in older asymptomatic men: The PREADViSE trial

byAnees DaudandShayna Bejaimal
March 23, 2017
in Cardiology, Chronic Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Based on this double-blind randomized, controlled trial which evolved into a cohort study, asymptomatic men taking vitamin E, selenium or a combination of the two did not have decreased risk of dementia as compared to men taking placebo.

2. When the study transitioned from a randomized, controlled trial to a cohort study, there was a significant reduction in the size of the study population and supplement exposure decreased, which may have resulted in an under-powered study.

Evidence Rating Level: 2 (Good)

Study Rundown: Basic science research has suggested that oxidative stress plays a role in the development of dementia, however it is unclear if antioxidant supplements help to decrease the risk of dementia. This study, which was initially a double-blind RCT which then transitioned into a cohort study, aimed to determine if antioxidant supplements, vitamin E and selenium used alone or in combination, could decrease the risk of dementia in asymptomatic older men.

The incidence of dementia was 4.4%. However, men receiving vitamin E or selenium or both did not have a lower risk of dementia as compared to men taking placebo. All men were followed for 5.4 years but a subset of men were followed for an additional 6 years. Strengths of this study included an initial study population that was large and the randomized design, however at the time of change to a cohort design, there was a significant decrease in the size of the study population, exposure to the antioxidants, and there was reduced patient-years of follow up. All of this under-powered the study. Additionally, a positive result on the dementia screening tool did not always lead participants to follow up appropriately, which may have led to under-diagnosis of the disease. Lastly, the effects of earlier and longer administration of the studied antioxidants may be required to see appropriate effects.

Click to read the study, published in JAMA Neurology

Relevant Reading: Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

RELATED REPORTS

Both night and non-shift shift work associated with increased dementia risk

The 2 Minute Medicine Podcast Episode 4

Use of restorative hearing aid devices improves cognition and reduces risk of dementia in patients with hearing loss

In-Depth [prospective cohort]: This randomized trial was initially a part of a parent study SELECT (double-blind RCT to determine the effectiveness of antioxidant supplementation in preventing prostate cancer). The PREADViSE Trial (Prevention of Alzheimer’s Disease by Vitamin E and Selenium) included a subset from the SELECT trial of men 60 years and older without dementia between 2002 and 2008. These men also did not have any history of serious head injury or substance abuse. SELECT was supposed to continue until 2012, however in 2008 SELECT was stopped due to findings from a futility analysis. The PREADViSE trial continued as a cohort study where 56.6% of the original sample continued into the cohort. The original 7,540 men were randomized into four groups: vitamin E only, selenium only, both vitamin E and selenium or placebo. All participants were followed for 5.4 years to determine the development of dementia using a 2-stage screen. The men who continued in the PREADViSE cohort were followed for an additional 6 years. Cox proportional hazards models and modified intention-to-treat was used for statistical analysis.

Dementia incidence was 4.4% (325 of 7338 men) and risk of dementia was not significantly different between the four study arms: vitamin E hazard ratio (HR) 0.88 (95% CI 0.64-1.20), selenium HR 0.83 (95% 0.60-1.13) and combination of vitamin E and selenium HR 1.00 (95% CI 0.75-1.35) as compared to placebo. These hazard ratios were adjusted for participant demographic information and baseline self-reported comorbidities.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antioxidantsdementia
Previous Post

2 Minute Medicine Rewind March 20, 2017

Next Post

Effective subcutaneous C1-inhibitor for hereditary angioedema prophylaxis: The COMPACT trial

RelatedReports

Chronic Disease

Both night and non-shift shift work associated with increased dementia risk

December 21, 2022
2MM Podcast

The 2 Minute Medicine Podcast Episode 4

December 15, 2022
Patient Basics: Hearing Loss in Adults
Neurology

Use of restorative hearing aid devices improves cognition and reduces risk of dementia in patients with hearing loss

December 6, 2022
Combined MRI and NIH stroke scores may predict stroke prognosis
Chronic Disease

Spirituality may aid patients with neurological diseases cope with their illness

November 2, 2022
Next Post

Effective subcutaneous C1-inhibitor for hereditary angioedema prophylaxis: The COMPACT trial

Medicaid home-visitation program linked to reduced infant mortality

Reduced yet persistent incidence of vertical HIV transmission in the United States

Tonsillectomy may have short-term benefits in recurrent throat infection

AAP issues policy statement on children in kinship care

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality
  • Concordance of diagnosis of autism spectrum disorder made by pediatricians vs multidisciplinary specialist teams
  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options